FINWIRES · TerminalLIVE
FINWIRES

HSBC Adjusts Applied Materials Price Target to $522 From $517, Maintains Buy Rating

By

Applied Materials (AMAT) has an average rating of buy and mean price target of $504.16, according to analysts polled by FactSet.

Price: $429.54, Change: $-11.02, Percent Change: -2.50%

Related Articles

Australia

Citigroup Adjusts Akamai Technologies Price Target to $160 From $110, Maintains Neutral Rating

Akamai Technologies (AKAM) has an average rating of overweight and mean price target of $157.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $152.59, Change: $-3.08, Percent Change: -1.98%

$AKAM
Australia

Diana Shipping Unit Extends Time Charter Contract With Oldendorff Carriers for Polymnia Vessel

Diana Shipping (DSX) said Friday that a subsidiary has extended the time charter contract with Oldendorff Carriers for Post-Panamax dry bulk vessel m/v Polymnia.The shipping company said the gross charter rate is $20,000 per day, minus a 5% commission paid to third parties, under the new charter period beginning June 1 through March 1, 2027, at the earliest and April 30, 2027, at the latest.Diana Shipping said it expects the extension to generate about $5.4 million of gross revenue for the minimum scheduled period of the time charter.Shares of Diana Shipping were down 1.5% in early trading Friday.Price: $2.72, Change: $-0.04, Percent Change: -1.52%

$DSX
Australia

Veracyte Secures Medicare Coverage for Bladder Cancer Monitoring Test

Veracyte (VCYT) said Friday its TrueMRD Monitoring Test received Medicare coverage for patients with muscle-invasive bladder cancer.The diagnostic tool is approved for tracking disease recurrence following treatment, and it detected disease return median of 131 days earlier than standard imaging during clinical studies, the company said.The product will be commercially available for healthcare providers to order beginning June 1, Veracyte said.Shares of the company were down 1.1% in Friday trading.Price: $38.27, Change: $-0.63, Percent Change: -1.62%

$VCYT